The US Army Medical Research and Development Command, a division of the Department of Defense, awarded a $2.7 million grant to Dr. Ann Marie Warren, PhD, ABPP, principal investigator for Baylor Scott & White Research Institute, to research prevent Post-tra
...
In collaboration with Exact Sciences, Baylor Scott & White Research Institute are now enrolling its first patients in the Texas Multi-Cancer Early Detection (MCED) Registry.
Baylor University Medical Center’s uterus transplant program—the largest of its kind in the world—published the results of an eight-year trial in JAMA, finding the procedure is safe and effective, resulting in a high rate of live births. The seminal study
...
The study results show exciting immune responses in patients with operable esophageal or gastroesophageal cancers given neoadjuvant immunotherapy and highlight the potential for monitoring circulating tumor DNA as a predictor for future intervention.
After more than 18 months of working to meet the criteria to become an authorized treatment center,
Baylor University Medical Center is poised to be one of the first in the nation to offer a newly FDA-approved tumor-infiltrating lymphocytes (TIL) cellula
...
Baylor Scott & White Medical Center – Temple is celebrating 125 years of offering patient-centered care to Central Texans and those who travel from around the state and country to receive care.
Baylor Scott & White – College Station Region continues to invest in medical facilities and services, increasing access to convenient, quality patient care options for the Brazos Valley.
In this newly created role, effective June 20th, Dr. Arroliga will partner with leaders across the system to identify, evaluate and pursue clinical innovations designed to improve patient experiences.
The newly created partnership will create a high-quality continuum of at-home care that encourages patient choice, reduces costs and improves outcomes.
